ArticleJournal of animal science2026
In vitro investigation of host Synaptogyrin-2 role in BVDV-1 replication.
Article in Journal of animal science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Bovine viral diarrhea virus type 1 (BVDV-1) is an RNA virus known for lifelong persistent infection in affected animals and substantial economic impact in cattle. While current approaches of infection control rely on biosecurity and immunization, recent advances in genome editing provide opportunities for improving genetic resistance of livestock to viral diseases. Any improvements in our understanding of the role of host genes in viral replication could lead to new gene-editing applications, supporting future efforts to control BVDV-1 worldwide. Recent evidence demonstrates that Synaptogyrin-2 (SYNGR2) gene plays a role in the replication of DNA and RNA viruses across different hosts, from humans to pigs. Given the functions of SYNGR2 in pathogen entry and viral replication, this study aimed to assess the role of this gene in BVDV-1 infection. The BVDV-1 strain used in the study was propagated in Madin-Darby bovine kidney (MDBK) cells and sequenced using Oxford Nanopore Technology. The sequencing reads were subjected to de novo genome assembly, exhibiting substantial similarity with Singer Arg BVDV-1 strain (97.75%). A SYNGR2 knock-out (KO) MDBK clone was generated via CRISPR-Cas9 gene editing. The KO clone included a 163 bp deletion in the mRNA of the SYNGR2 gene, predicted to result in a shift in the reading frame starting after residue 118, affecting the second intraluminal loop and the carboxyl terminal domain. There was no difference in viral replication between wild type and SYNGR2 KO MDBK clone, measured in cells (P > 0.08) and supernatant (P > 0.21), suggesting that SYNGR2 is less likely critical for the replication of BVDV-1. Our findings could be a result of key differences from previous findings that involved SYNGR2 in the replication of DNA and RNA viruses, emphasizing the need for exploring in more detail the role of host genes in BVDV-1 replication and pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.